Skip to main content

Advertisement

Table 1 Patients’ baseline data

From: Comparison of different laboratory tests in the evaluation of hemorrhagic risk of patients using rivaroxaban in the critical care setting: diagnostic accuracy study

Gender n (%)
 Female 20 (50)
 Male 20 (50)
Rivaroxaban dosage n (%)
 10 mg/day 12 (30.0)
 15 mg/day 19 (47.5)
 20 mg/day 9 (22.5)
Age  
 Average (standard deviation) 69 (21)
 Minimum and maximum age 27–95